
ISPOR EU
- This event has passed.

CBPartners will be presenting at the virtual ISPOR Europe 2020 conference – our schedule is outlined below:
IP14: THE SAR-2-COV VACCINE: WHAT DOES AN OPTIMAL VACCINATION STRATEGY LOOK LIKE?
CBPartners’ issue panel will bring together stakeholders from public health bodies and industry to discuss the optimal SAR-2-COV vaccination strategy approach for global public health systems.
MODERATOR: Bami Oshinowo, MSc, Principal and EU Center of Excellence Lead, CBPartners
PANELISTS: Mark Joinnides, MSE, Global Sales Director, COVAXX; Hernan Rosenberg, PhD, Professor of Public Health University of Chile & Universidad de la Frontera
LOCATION: Breakout Room 5
DATE: NOV 19, 2020
TIME: 14:30 – 15:30 (CET)
Research Posters:
- [PCN233] COMMUNICATING VALUE WITH TUMOR-AGNOSTIC THERAPIES
- [PNS103] HARNESSING THE POWER OF REAL-WORLD EVIDENCE REGISTRIES
- [PNS189] DEMONSTRATING PAYER VALUE FOR ADJUVANT, NEOADJUVANT, AND CONSOLIDATION THERAPIES
- [PCN205] COST CONTAINMENT IN THE NETHERLANDS: LOCK IT DOWN
- [PMH36] SCHIZOPHRENIA AND HTA DECISION MAKING
- [PCN231] ASSESSING EU HTA TRENDS FOR PD-(L)1S OVER THE YEARS
- [PNS164] PAYER ASSESSMENTS OF CELL AND GENE THERAPIES: WHEN IS A DRUG NOT A DRUG?
- [PNS72] FROM VOLUME-TO-VALUE IN LATAM – A 6-STEP PROCESS